Faculty Bibliography

OBJECTIVE:This study evaluated changes in positive affect within cognitive-behavioral treatments (CBT) for anxiety disorders. It was hypothesized that there would be significantly greater increases in positive affect in CBT conditions compared to the waitlist, and particularly higher in the Unified Protocol (UP) than the single disorder protocols (SDP) given the UP's focus on emotions (including positive emotions) rather than symptoms. METHOD:Patients with heterogeneous anxiety disorders (N = 223) were randomly assigned to the UP, SDP or waitlist. Linear mixed model regression (intent to treat) analyses were used to compare change in positive affect, quality of life, and savoring between patients in the treatment conditions (UP and SDP) versus waitlist conditions. Between condition effect sizes were calculated to assess the magnitude of difference within conditions at post-treatment. RESULTS:Results indicated a significant Group (treatment vs. waitlist) × Time (pre- post-treatment) interaction (F(1, 154.36) = 6.75; p = .01) for positive affect in which the treatment group showed significant improvements in positive affect pre- to post-treatment (ESsg = 0.37, SEsg = 0.09, 95% CI [0.20: 0.54]) and the waitlist condition did not. There were no differences between UP and SDP conditions in positive affect at baseline or at post-treatment. CONCLUSIONS:These results suggest CBT, which typically focuses on reductions in negative affect, may also improve positive affect. The importance of future research evaluating, targeting, and improving positive affect in CBT trials is discussed. Clinicaltrials.gov Identifier: NCT01243606.

Detecting pathogen threats and avoiding disease is fundamental to human survival. The behavioral immune system (BIS) framework outlines a set of psychological functions that may have evolved for this purpose. Disgust is a core emotion that plays a pivotal role in the BIS, as it activates the behavioral avoidance motives that prevent people from being in contact with pathogens. To date, there has been little agreement on how disgust sensitivity might underlie moral judgments. Here, we investigated moral violations of "purity" (assumed to elicit disgust) and violations of "harm" (assumed to elicit anger). We hypothesized that individual differences in BIS-related traits would be associated with greater disgust (vs. anger) reactivity to, and greater condemnation of Purity (vs. Harm) violations. The study was pre-registered (https://osf.io/57nm8/). Participants (N = 632) rated scenarios concerning moral wrongness or inappropriateness and regarding disgust and anger. To measure individual differences in the activation of the BIS, we used our recently developed Body Odor Disgust Scale (BODS), a BIS-related trait measure that assesses individual differences in feeling disgusted by body odors. In line with our predictions, we found that scores on the BODS relate more strongly to affective reactions to Purity, as compared to Harm, violations. In addition, BODS relates more strongly to Moral condemnation than to perceived Inappropriateness of an action, and to the condemnation of Purity violations as compared to Harm violations. These results suggest that the BIS is involved in moral judgment, although to some extent this role seems to be specific for violations of "moral purity," a response that might be rooted in disease avoidance. Data and scripts to analyze the data are available on the Open Science Framework (OSF) repository: https://osf.io/tk4x5/. Planned analyses are available at https://osf.io/x6g3u/.